Nasus Pharma Ltd (NSRX)
AMEX · Common · CUSIP M7071P109
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for NSRX and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
M7071P109
Business: Nasus Pharma Ltd is a clinical-stage biopharmaceutical company developing intranasal drug delivery products.

Company Contact

CEO
Dan Teleman
CFO
Eyal Rubin
Investor Relations
info@nasuspharma.com
SEC EDGAR Filings
View filings »